{"id":807,"date":"2007-09-20T12:03:47","date_gmt":"2007-09-20T12:03:47","guid":{"rendered":"https:\/\/abolongroup.com\/?post_type=abolon-transactions&#038;p=807"},"modified":"2024-08-07T12:05:28","modified_gmt":"2024-08-07T12:05:28","slug":"roha-arzneimittel-has-acquired-boerner-arzneimittel","status":"publish","type":"abolon-transactions","link":"https:\/\/abolongroup.com\/de\/abolon-transactions\/roha-arzneimittel-has-acquired-boerner-arzneimittel\/","title":{"rendered":"Roha Arzneimittel has acquired Boerner Arzneimittel"},"content":{"rendered":"<p>In September 2007, roha arzneimittel GmbH, the Germany based nutritional ingredients company,\u00a0acquired Boerner Arzneimittel GmbH, the Germany based manufacturer and distributor of pharmaceuticals and cosmetic products, for an undisclosed consideration. Abolon initiated the transaction and acted as advisor to roha arzneimittel.<\/p>\n<p>roha expects a turnover of EUR 40m for the year 2007. The acquisition will strengthen roha\u2019s position as a distributor and manufacturer of health products. Post acquisition, Boerner\u2019s employees will be headed under roha arzneimittel GmbH.<\/p>\n","protected":false},"template":"","class_list":["post-807","abolon-transactions","type-abolon-transactions","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/abolon-transactions\/807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/abolon-transactions"}],"about":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/types\/abolon-transactions"}],"wp:attachment":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/media?parent=807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}